27923790|t|Dynamin-related protein 1 mediates low glucose - induced endothelial dysfunction in human arterioles
27923790|a|Intensive glycemic regulation has resulted in an increased incidence of hypoglycemia. Hypoglycemic burden correlates with adverse cardiovascular complications and contributes acutely and chronically to endothelial dysfunction. Prior data indicate that mitochondrial dysfunction contributes to hypoglycemia - induced endothelial dysfunction, but the mechanisms behind this linkage remain unknown. We attempt to determine whether clinically relevant low-glucose (LG) exposures acutely induce endothelial dysfunction through activation of the mitochondrial fission process. Characterization of mitochondrial morphology was carried out in cultured endothelial cells by using confocal microscopy. Isolated human arterioles were used to explore the effect LG - induced mitochondrial fission has on the formation of detrimental reactive oxygen species (ROS), bioavailability of nitric oxide (NO), and endothelial-dependent vascular relaxation. Fluorescence microscopy was employed to visualize changes in mitochondrial ROS and NO levels and videomicroscopy applied to measure vasodilation response. Pharmacological disruption of the profission protein Drp1 with Mdivi-1 during LG exposure reduced mitochondrial fragmentation among vascular endothelial cells (LG: 0.469; LG + Mdivi-1: 0.276; P = 0.003), prevented formation of vascular ROS (LG: 2.036; LG + Mdivi-1: 1.774; P = 0.005), increased the presence of NO (LG: 1.352; LG + Mdivi-1: 1.502; P = 0.048), and improved vascular dilation response to acetylcholine (LG: 31.6%; LG + Mdivi-1; 78.5% at maximum dose; P < 0.001). Additionally, decreased expression of Drp1 via siRNA knockdown during LG conditions also improved vascular relaxation. Exposure to LG imparts endothelial dysfunction coupled with altered mitochondrial phenotypes among isolated human arterioles. Disruption of Drp1 and subsequent mitochondrial fragmentation events prevents impaired vascular dilation, restores mitochondrial phenotype, and implicates mitochondrial fission as a primary mediator of LG - induced endothelial dysfunction .NEW & NOTEWORTHY Acute low-glucose exposure induces mitochondrial fragmentation in endothelial cells via Drp1 and is associated with impaired endothelial function in human arterioles. Targeting of Drp1 prevents fragmentation, improves vasofunction, and may provide a therapeutic target for improving cardiovascular complications among diabetics .Listen to this article's corresponding podcast @ http://ajpheart.podbean.com/e/mitochondrial-dynamics-impact-endothelial-function/.
27923790	0	25	Dynamin-related protein 1	T116,T126	C0669938
27923790	26	34	mediates	T169	C0205245
27923790	35	46	low glucose	T109,T121,T123	C0017725
27923790	49	56	induced	T169	C0205263
27923790	57	80	endothelial dysfunction	T047	C0856169
27923790	84	89	human	T016	C0086418
27923790	90	100	arterioles	T023	C0003847
27923790	111	130	glycemic regulation	T038	C1327622
27923790	150	159	increased	T081	C0205217
27923790	160	169	incidence	T081	C0021149
27923790	173	185	hypoglycemia	T047	C0020615
27923790	187	199	Hypoglycemic	T047	C0020615
27923790	200	206	burden	T078	C2828008
27923790	223	230	adverse	T169	C0001688
27923790	231	259	cardiovascular complications	T046	C0161816
27923790	276	283	acutely	T079	C0205178
27923790	288	299	chronically	T079	C0205191
27923790	303	326	endothelial dysfunction	T047	C0856169
27923790	334	338	data	T078	C1511726
27923790	353	378	mitochondrial dysfunction	T033	C4021734
27923790	394	406	hypoglycemia	T047	C0020615
27923790	409	416	induced	T169	C0205263
27923790	417	440	endothelial dysfunction	T047	C0856169
27923790	450	460	mechanisms	T169	C0441712
27923790	473	480	linkage	T169	C0205245
27923790	488	495	unknown	T080	C0439673
27923790	529	539	clinically	T080	C0205210
27923790	540	548	relevant	T080	C2347946
27923790	549	560	low-glucose	T109,T121,T123	C0017725
27923790	562	564	LG	T109,T121,T123	C0017725
27923790	566	575	exposures	T080	C0332157
27923790	576	583	acutely	T079	C0205178
27923790	584	590	induce	T169	C0205263
27923790	591	614	endothelial dysfunction	T047	C0856169
27923790	623	633	activation	T052	C1879547
27923790	641	670	mitochondrial fission process	T043	C0230871
27923790	672	688	Characterization	T052	C1880022
27923790	692	716	mitochondrial morphology	T033	C0243095
27923790	736	744	cultured	T169	C0205245
27923790	745	762	endothelial cells	T025	C0225336
27923790	772	791	confocal microscopy	T059	C0242842
27923790	793	801	Isolated	T169	C0205409
27923790	802	807	human	T016	C0086418
27923790	808	818	arterioles	T023	C0003847
27923790	844	850	effect	T080	C1280500
27923790	851	853	LG	T109,T121,T123	C0017725
27923790	856	863	induced	T169	C0205263
27923790	864	885	mitochondrial fission	T043	C0230871
27923790	897	906	formation	T169	C1522492
27923790	910	945	detrimental reactive oxygen species	T123	C1537052
27923790	947	950	ROS	T123	C1537052
27923790	953	968	bioavailability	T081	C0005508
27923790	972	984	nitric oxide	T121,T123,T197	C0028128
27923790	986	988	NO	T121,T123,T197	C0028128
27923790	995	1036	endothelial-dependent vascular relaxation	T042	C1258036
27923790	1038	1061	Fluorescence microscopy	T059	C0026022
27923790	1088	1095	changes	T169	C0392747
27923790	1099	1112	mitochondrial	T026	C0026237
27923790	1113	1116	ROS	T123	C1537052
27923790	1121	1123	NO	T121,T123,T197	C0028128
27923790	1124	1130	levels	T080	C0441889
27923790	1135	1150	videomicroscopy	T059	C0242940
27923790	1162	1169	measure	T081	C0079809
27923790	1170	1182	vasodilation	T042	C0042401
27923790	1183	1191	response	T169	C0205245
27923790	1193	1208	Pharmacological	T169	C0205464
27923790	1209	1219	disruption	T169	C0332453
27923790	1227	1245	profission protein	T116,T123	C0033684
27923790	1246	1250	Drp1	T116,T126	C0669938
27923790	1256	1263	Mdivi-1	T109	C2933581
27923790	1271	1273	LG	T109,T121,T123	C0017725
27923790	1274	1282	exposure	T080	C0332157
27923790	1283	1290	reduced	T080	C0392756
27923790	1291	1318	mitochondrial fragmentation	T043	C0230871
27923790	1325	1351	vascular endothelial cells	T025	C1257792
27923790	1353	1355	LG	T109,T121,T123	C0017725
27923790	1364	1366	LG	T109,T121,T123	C0017725
27923790	1369	1376	Mdivi-1	T109	C2933581
27923790	1397	1406	prevented	T169	C1292733
27923790	1407	1416	formation	T169	C1522492
27923790	1420	1428	vascular	T023	C0005847
27923790	1429	1432	ROS	T123	C1537052
27923790	1434	1436	LG	T109,T121,T123	C0017725
27923790	1445	1447	LG	T109,T121,T123	C0017725
27923790	1450	1457	Mdivi-1	T109	C2933581
27923790	1478	1487	increased	T081	C0205217
27923790	1492	1500	presence	T033	C0150312
27923790	1504	1506	NO	T121,T123,T197	C0028128
27923790	1508	1510	LG	T109,T121,T123	C0017725
27923790	1519	1521	LG	T109,T121,T123	C0017725
27923790	1524	1531	Mdivi-1	T109	C2933581
27923790	1556	1564	improved	T033	C0184511
27923790	1565	1582	vascular dilation	T042	C0042401
27923790	1583	1591	response	T169	C0205245
27923790	1595	1608	acetylcholine	T109,T121,T123	C0001041
27923790	1610	1612	LG	T109,T121,T123	C0017725
27923790	1621	1623	LG	T109,T121,T123	C0017725
27923790	1626	1633	Mdivi-1	T109	C2933581
27923790	1644	1651	maximum	T081	C0806909
27923790	1652	1656	dose	T081	C0178602
27923790	1684	1693	decreased	T081	C0205216
27923790	1694	1704	expression	T045	C1171362
27923790	1708	1712	Drp1	T116,T126	C0669938
27923790	1717	1722	siRNA	T114,T123	C1099354
27923790	1723	1732	knockdown	T063	C2350567
27923790	1740	1742	LG	T109,T121,T123	C0017725
27923790	1743	1753	conditions	T080	C0348080
27923790	1759	1767	improved	T033	C0184511
27923790	1768	1787	vascular relaxation	T042	C1258036
27923790	1789	1800	Exposure to	T080	C0332157
27923790	1801	1803	LG	T109,T121,T123	C0017725
27923790	1812	1835	endothelial dysfunction	T047	C0856169
27923790	1836	1843	coupled	T169	C1948027
27923790	1849	1856	altered	T169	C0392747
27923790	1857	1870	mitochondrial	T026	C0026237
27923790	1871	1881	phenotypes	T032	C0031437
27923790	1888	1896	isolated	T169	C0205409
27923790	1897	1902	human	T016	C0086418
27923790	1903	1913	arterioles	T023	C0003847
27923790	1915	1925	Disruption	T169	C0332453
27923790	1929	1933	Drp1	T116,T126	C0669938
27923790	1938	1948	subsequent	T079	C0332282
27923790	1949	1976	mitochondrial fragmentation	T043	C0230871
27923790	1984	1992	prevents	T169	C1292733
27923790	1993	2001	impaired	T169	C0221099
27923790	2002	2019	vascular dilation	T042	C0042401
27923790	2021	2029	restores	T169	C0205245
27923790	2030	2043	mitochondrial	T026	C0026237
27923790	2044	2053	phenotype	T032	C0031437
27923790	2070	2091	mitochondrial fission	T043	C0230871
27923790	2097	2104	primary	T080	C0205225
27923790	2105	2113	mediator	T080	C0205556
27923790	2117	2119	LG	T109,T121,T123	C0017725
27923790	2122	2129	induced	T169	C0205263
27923790	2130	2153	endothelial dysfunction	T047	C0856169
27923790	2172	2177	Acute	T079	C0205178
27923790	2178	2189	low-glucose	T109,T121,T123	C0017725
27923790	2190	2198	exposure	T080	C0332157
27923790	2199	2206	induces	T169	C0205263
27923790	2207	2234	mitochondrial fragmentation	T043	C0230871
27923790	2238	2255	endothelial cells	T025	C0225336
27923790	2260	2264	Drp1	T116,T126	C0669938
27923790	2272	2287	associated with	T080	C0332281
27923790	2288	2296	impaired	T169	C0221099
27923790	2297	2308	endothelial	T025	C0225336
27923790	2309	2317	function	T043	C0007613
27923790	2321	2326	human	T016	C0086418
27923790	2327	2337	arterioles	T023	C0003847
27923790	2339	2348	Targeting	T043	C0599894
27923790	2352	2356	Drp1	T116,T126	C0669938
27923790	2357	2365	prevents	T169	C1292733
27923790	2366	2379	fragmentation	T043	C0230871
27923790	2390	2402	vasofunction	T042	C1254358
27923790	2422	2433	therapeutic	T169	C0302350
27923790	2434	2440	target	T169	C1521840
27923790	2455	2483	cardiovascular complications	T046	C0161816
27923790	2490	2499	diabetics	T033	C0241863
27923790	2550	2631	http://ajpheart.podbean.com/e/mitochondrial-dynamics-impact-endothelial-function/	T170	C1704666